BlackRock, Inc. 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
5,976,266 7.500% |
556,241 (+10.26%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
5,420,025 8.000% |
1,622,456 (+42.72%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
3,797,569 6.500% |
387,711 (+11.37%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
3,409,858 6.000% |
3,409,858 (New Position) |
Filing |